Streetbeat News

Stock Prices

SBUX

Starbucks Corporation's CEO, Laxman Narasimhan, addressed vandalism at stores following pro-Palestinian comments by Starbucks Workers United amid the Israel-Hamas conflict. The company is trying to halt boycott calls and has distanced itself from the union's remarks. Starbucks filed a lawsuit against the union for trademark infringement in October, emphasizing its stance against hate and violence. SBUX shares dipped slightly in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

December 20, 2023 | 11:27 am

CPNG

UBS analyst Jennifer Han downgraded Coupang (NYSE:CPNG) from Buy to Neutral and reduced the price target from $26 to $18.5, indicating a more cautious outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 11:18 am

HEI

Morgan Stanley analyst Kristine Liwag has downgraded Heico (NYSE:HEI) from Equal-Weight to Underweight and reduced the price target from $184 to $174.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 11:16 am

YOU

Wells Fargo analyst Michael Turrin downgraded Clear Secure (NYSE:YOU) from Equal-Weight to Underweight and set a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 11:10 am

RNG

Wells Fargo analyst Michael Turrin downgraded RingCentral (NYSE:RNG) from Overweight to Equal-Weight and set a price target of $36.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 11:07 am

MARA

HC Wainwright & Co. analyst Kevin Dede has reaffirmed a Buy rating on Marathon Digital Holdings (NASDAQ:MARA) and increased the price target from $20 to $24.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 11:07 am

ZM

Wells Fargo analyst Phil Winslow has downgraded Zoom Video Communications (ZM) from Equal-Weight to Underweight and set a new price target of $70.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 10:56 am

MRTX

Citigroup analyst Yigal Nochomovitz has downgraded Mirati Therapeutics (MRTX) from Buy to Neutral, while increasing the price target from $48 to $59. This reflects a more cautious stance on the stock's current valuation, but also acknowledges potential upside from the previous target.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 10:54 am

CRM

Wells Fargo analyst Michael Turrin downgraded Salesforce (CRM) from Overweight to Equal-Weight and set a price target of $280.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 10:52 am

NMRK

Piper Sandler analyst Alexander Goldfarb upgraded Newmark Group (NASDAQ:NMRK) from Neutral to Overweight and increased the price target from $7 to $13, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 10:50 am